HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taishi Hashiguchi Selected Research

Larsen-Like Syndrome

7/2011Faulty initiation of proteoglycan synthesis causes cardiac and joint defects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taishi Hashiguchi Research Topics

Disease

6Fibrosis (Cirrhosis)
04/2024 - 01/2016
4Inflammation (Inflammations)
12/2020 - 01/2018
4Non-alcoholic Fatty Liver Disease
12/2020 - 01/2018
4Neoplasms (Cancer)
01/2020 - 12/2008
3Alcoholic Fatty Liver
01/2023 - 01/2016
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2019 - 01/2016
2Insulin Resistance
04/2024 - 12/2020
2Liver Diseases (Liver Disease)
12/2020 - 01/2018
2Necrosis
01/2018 - 01/2015
2Neoplasm Metastasis (Metastasis)
01/2015 - 12/2008
1Fatty Liver
04/2024
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023
1Carcinogenesis
01/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Cytopenia
01/2018
1Dyslipidemias (Dyslipidemia)
01/2018
1Primary Myelofibrosis (Myelosclerosis)
01/2018
1Colitis
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2015
1Joint Dislocations
07/2011
1Larsen-Like Syndrome
07/2011
1Lewis Lung Carcinoma
12/2008

Drug/Important Bio-Agent (IBA)

4Messenger RNA (mRNA)IBA
01/2018 - 01/2015
3Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2016 - 12/2008
2OxysterolsIBA
04/2024 - 12/2020
2CholesterolIBA
04/2024 - 12/2020
2LipidsIBA
04/2024 - 01/2018
2CytokinesIBA
01/2020 - 01/2018
2Small Interfering RNA (siRNA)IBA
01/2016 - 01/2015
2SulfotransferasesIBA
01/2016 - 01/2015
2Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2015
2CarbohydratesIBA
01/2016 - 01/2015
2CollagenIBA
01/2016 - 01/2016
1Insulin (Novolin)FDA Link
04/2024
1Interleukin-17 (Interleukin 17)IBA
01/2023
1AdiponectinIBA
01/2023
1Imiquimod (Aldara)FDA LinkGeneric
01/2023
1Biological FactorsIBA
12/2020
1steroidogenic acute regulatory proteinIBA
12/2020
1GlycosaminoglycansIBA
01/2020
1paramylonIBA
01/2019
1nasIBA
01/2018
1gemcabeneIBA
01/2018
1ruxolitinibIBA
01/2018
111- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
01/2018
1Telmisartan (Micardis)FDA Link
01/2018
1AngiotensinsIBA
01/2018
1Hemoglobins (Hemoglobin)IBA
01/2018
1Streptozocin (Streptozotocin)FDA Link
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Keratin-18 (Keratin 18)IBA
01/2018
1Thioacetamide (Thioacetamid)IBA
01/2016
1DisaccharidesIBA
01/2016
1cenicrivirocIBA
01/2016
1Interleukin-6 (Interleukin 6)IBA
01/2016
1Dextran SulfateIBA
01/2016
1Collagen Type I (Type I Collagen)IBA
01/2016
1A73025IBA
01/2015
1EnzymesIBA
01/2015
1Proteoglycans (Proteoglycan)IBA
07/2011
1Dermatan SulfateIBA
12/2008
1EpitopesIBA
12/2008

Therapy/Procedure

1Oral Administration
01/2019